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Abstract
Objective: To identify current risk factors for hepatitis C virus (HCV) transmission in Greater Cairo.
Design and Setting: A 1:1 matched case-control study was conducted comparing incident acute symptomatic hepatitis C
patients in two ‘‘fever’’ hospitals of Greater Cairo with two control groups: household members of the cases and acute
hepatitis A patients diagnosed at the same hospitals. Controls were matched on the same age and sex to cases and were all
anti-HCV antibody negative. Iatrogenic, community and household exposures to HCV in the one to six months before
symptoms onset for cases, and date of interview for controls, were exhaustively assessed.
Results: From 2002 to 2007, 94 definite acute symptomatic HCV cases and 188 controls were enrolled in the study. In
multivariate analysis, intravenous injections (OR=5.0; 95% CI=1.2–20.2), medical stitches (OR=4.2; 95% CI=1.6–11.3),
injection drug use (IDU) (OR=7.9; 95% CI=1.4–43.5), recent marriage (OR=3.3; 95% CI=1.1–9.9) and illiteracy (OR=3.9;
95% CI=1.8–8.5) were independently associated with an increased HCV risk.
Conclusion: In urban Cairo, invasive health care procedures remain a source of HCV transmission and IDU is an emerging
risk factor. Strict application of standard precautions during health care is a priority. Implementation of comprehensive
infection prevention programs for IDU should be considered.
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Introduction
The highest HCV prevalence in the world occurs in Egypt at an
estimated 12% [1], i.e. 10 to 20 fold higher than in Northern
Europe [2] or in the United States [3]. The bulk of chronic
infection is age-related [4] and occurs among persons of rural
origin. Cohort studies have estimated a 9% prevalence and 0.8/
1000 person-years incidence in Upper Egypt, and a 24%
prevalence and 6.8/1000 incidence in the Nile Delta [5,6].
The widespread schistosomiasis treatment campaigns with
intravenous tartar emetic, carried out in the countryside in the
60’s- early 80’s, ignited this epidemic through reuse of
insufficiently sterilised needles and syringes [7]. Since then,
cross-sectional studies have shown unsafe injection practices,
history of blood transfusion, invasive medical procedures, and
instrument-assisted birth deliveries as associated with HCV
infection [8–10]. Intra-familial transmission may also have played
an important role, as evidenced in two recent cohort studies
[6,11].
However, HCV transmission has been studied almost exclu-
sively in rural areas, with only two uncontrolled studies reporting
on urban hepatitis C patients [12,13]. After last decades of large
rural exodus leading to the suburbs of Cairo, 45% of the Egyptian
population is urban (Source CAPMAS, 2000). In order to identify
current risk factors for HCV infection in urban Egypt, we have
conducted a case-control study recruiting incident HCV case
patients, i.e. recently acquired infections, in two hospitals serving
Greater Cairo (Cairo and its suburbs).
Methods
Participants’ recruitment and questionnaire
From April 2002 to June 2007, a 1:1 matched case-control study
with two control groups was conducted. Incident acute symptom-
atic hepatitis C patients were enrolled as cases either (i) before
seroconversion, with negative anti-HCV antibody and positive
HCV RNA laboratory results or (ii) with rapid seroconversion:
positive anti-HCV antibody and positive HCV RNA associated
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7193with alanine aminotransferase (ALT) $20 times the ULN
($800 IU/L). The high ALT threshold was used to exclude
ALT flares in patients with chronic hepatitis C.
Two control groups were matched on age (61 year) and sex:
household members (family controls) and acute hepatitis A
patients (HAV controls) diagnosed at the same hospitals. Only
laboratory confirmed anti-HCV negative controls were included
in the study.
Since age at infection profile of HAV and HCV are overlapping
in the age group between 15–40 years of age, only cases and
controls in this age range were considered to allow proper
matching.
Acute hepatitis patients were identified at the two ‘fever’
hospitals of Greater Cairo, Abbassia and Imbaba. ‘Fever’
Hospitals are large public and non-paying hospitals whose patient
population derives mostly from low socioeconomic groups
(methods published elsewhere [12]). In- and outpatients with
recent (,3 weeks) symptoms suggestive of hepatitis (fever or
jaundice) were invited to participate in the study. After providing
written informed consent (from one of the parents if less than 18
years of age), they answered orally administered standardised
questionnaires covering socio-demographic characteristics, present
and past health conditions, and exposure to potential risk factors
for viral hepatitis in the one to six months before onset of illness.
Regarding socio-demographic variables, illiteracy (the inability to
read and write) and marriage duration (aggregated on recently
married versus married for longer than one year) were of special
interest.
Other exposures in the one to six months before symptoms
onset included a history of invasive medical procedures (e.g.,
surgery, intravenous catheter, endoscope, blood transfusion, IV
drip infusions, injections, haemodialysis, biopsy, endoscope,
sclerotherapy of varicose veins), obstetrical procedures (caesarean
section, episiotomy, uterine curettage) and dental treatment.
Information on the following community–acquired exposures
was also collected: circumcision, ear-piercing, shaving at barber-
shops, sharing razors or nail trimmers with family members,
manicure or pedicure at beauty salons, tattooing, and acupunc-
ture. Due to their sensitive nature, questions on high-risk behavior
such as alcohol consumption, drug use (e.g., sniffing or intravenous
(IDU)) and multiple sexual partners were only asked to men.
During counselling, case patients were invited to ask their families
to participate in the study. After providing informed consent,
family members answered the same questionnaire regarding
exposures at risk in the one to 6 months before interview.
Approval for the study was obtained from the Institutional
Review Board of the Egyptian Ministry of Population and Health
(MoPH) and the Ethics Committee of the National Hepatology
and Tropical Medicine Research Institute (NHTMRI, Egypt).
Laboratory testing
A 10 ml venous blood sample was collected. Patients were tested
for standard liver functions (ALT), aspartate aminotransferase
(AST), total and indirect bilirubin, alkaline phosphatase) and for
the following hepatitis markers: anti-HAV IgM (HAVABH,M
EIA, Abbott Laboratories, Diagnostics Division, IL, USA), anti-
HBc IgM (CORZYMEH, M rDNA, Abbott Laboratories,
Diagnostics Division, IL, USA) and HBs antigen (AUSZYME
MONOCLONALH, third generation EIA, Abbott Laboratories,
Diagnostics Division, IL, USA). In patients with non-A non-B
hepatitis, anti-HCV antibody and HCV-RNA were assessed
serologically (INNOTEST
H HCV Ab IV, Innogenetics, Ghent,
Belgium) and using polymerase chain reaction (PCR) (nested
reverse transcriptase PCR by in house assay using 59 UTR
primers) [14] testing, respectively. In patients with positive HCV
antibodies and RNA, exacerbation of chronic hepatitis C by other
infectious agents was ruled out using reverse transcriptase PCR for
HEV-RNA (in house assay using ORF1 and ORF2 primers) and
serological testing [anti Epstein-Barr virus (EBV) IgM (ETI-EBV-
M reverse P001605, Dia Sorin, Vercelle, Italy), anti-cytomegalo-
virus (CMV) IgM (AXSYM
H system-CMV-IgM, Abbott Labora-
tories, Wiesbaden, Delknheim, Germany), and anti-Toxoplasma
IgM (AXSYM
H system-Toxo-IgM, Abbott Laboratories, Wiesba-
den, Delknheim, Germany)].
Family controls were anti-HCV antibody and HCV-RNA
tested using the same techniques.
Statistical analysis
Univariate ORs and 95% confidence intervals (95% CI) were
estimated for each potential risk factor using a conditional logistic
regression model (to account for the matched design) and
significance was assessed by the Wald test. Interactions were
tested by introducing interaction terms in the model.
Since both control groups had the same odds of exposures for
most exposures, as can be seen in Tables 1 to 3, we believe that
they were properly sampling the same source population of cases,
i.e., those who would have gone for care at the fever hospitals had
they developed acute hepatitis C. As a result, we decided to group
them to increase the study power.
Variables with p-values,0.20 were entered into a multivariate
conditional logistic regression model to simultaneously examine
their independent effect. The final model was obtained through
stepwise deletion of variables until all predictors left had
p-values,0.05.
With this sample size, the study had an 80% power to document
odds ratios (OR) above 2.0 for exposures present among 50% of
controls, and 3.5 for exposures present among 5% of controls
(a=0.05; two-sided tests).
Data were analyzed using STATA 9.0 software (Stata
Corporation, College Station, USA).
Results
Description of the study population
Ninety four cases and their 188 controls, 94 HAV controls and
94 family controls, were enrolled in the study. Mean age (6SD) of
the cases was 25.9 (65.9) years and 70% (n=66) were males.
Case patients being symptomatic by definition, the prevalence
of symptoms was the following: fever (44.7%), jaundice (95.7%),
light clay stools (87.2%), dark urine (96.8%), abdominal pain
(82.9%) and vomiting (63.8%). The median bilirubin level (mg/
dL) was 7.2 (Interquartile range (IQR)=4.7–11) and the median
ALT level (IU/L) was 884 (IQR=625-1350). As expected due to
matching design, mean age and male proportion were similar
between cases and controls (Table 1). Prevalences of exposure to
studied risk factors were also similar between the two control
groups, as shown in Tables 1 to 3.
Matched analysis
In univariate analysis, iatrogenic factors (Table 2) statistically
associated with HCV infection were history of hospitalization,
having major surgery, receiving wound stitches in emergency
rooms, intravenous (IV) cannula, and IV injections but not
intramuscular injections. In women, child birth and caesarean
section were associated with increased risk of HCV infection,
although the association was marginally significant for delivery
(p=0.06).
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2002-7.
HCV Cases HAV Controls Family Controls OR*(95% CI) p-value
N=94 N=94 N=94
Invasive medical procedures
Hospital Admission 15 (16.0) 3 (3.2) 5 (5.3) 3.8 (1.6–8.8) 0.002
Admission to Intensive care 0 0 0 ––
Surgery 8 (8.5) 2 (2.1) 1 (1.1) 5.3 (1.4–20.1) 0.01
Stitches 21 (22.3) 6 (6.4) 3 (3.2) 5.1 (2.2–11.5) ,0.001
Intravenous injections 9 (9.6) 1 (1.1) 3 (3.2) 4.3 (1.3–14) 0.01
Intramuscular injections 13 (13.8) 12 (12.8) 18(19.1) 0.8 (0.4–1.7) 0.63
Intravenous cannula 13 (13.8) 5 (5.3) 4 (4.3) 3.3 (1.3–8.5) 0.01
Catheter 0 1 (1.1) 0 ––
Endoscopy 1 (1.1) 0 0 ––
Laparoscopy 0 1 (1.1) 0 ––
Abscess incision 3 (3.2) 2 (2.1) 0 3.0 (0.5–17.9) 0.22
Ascites tapping 1 (1.1) 0 0 ––
Blood donation 5 (5.3) 5 (5.3) 3 (3.2) 1.3 (0.4–3.8) 0.70
Blood transfusion 0 0 0 ––
Obstetric exposures
a
Birth delivery 4 (14.3) 1 (3.6) 1 (3.6) 6.6 (0.7–60.9) 0.06
Cesarean section 3 (10.7) 0 0 – 0.05
Dental treatment
Any 16 (17.0) 17 (18.1) 14(14.9) 1.0 (0.5–1.9) 1.00
Teeth extraction 12 (12.8) 11 (11.7) 5 (5.3) 1.5 (0.7–3.4) 0.30
Gum treatment 3 (3.2) 3 (3.2) 4 (4.3) 0.8 (0.2–3.2) 0.73
Filling cavities 2 (2.1) 1 (1.1) 2 (2.1) 1.2 (0.2–7.0) 0.88
Injected anesthesia 13 (13.8) 12 (12.8) 7 (7.4) 1.3 (0.6–2.8) 0.44
NOTE: Data are no. (%) of participants.
OR
*, unadjusted odds ratio comparing cases to the two control groups combined CI, confidence interval.
aOnly women included (N=84).
doi:10.1371/journal.pone.0007193.t002
Table 1. Socio-demographic characteristics of acute hepatitis C cases and controls sex- and 61 year age-matched, Greater Cairo,
2002-7.
HCV cases HAV Controls Family Controls OR
* (95% CI) p-value
N 94 94 94
Mean age (years) 25.9 (65.9) 25.4 (66.2) 25.3 (66.0) NA NA
Males 66 (70) 66 (70) 66 (70) NA NA
Education ,0.001
Ability to read and write 53 (56.4) 77 (81.9) 80 (85.1) 1
Illiteracy 41 (43.6) 17 (18.1) 14 (14.9) 4.5 (2.4–8.6)
Marriage duration 0.01
Single 46 (48.9) 63 (67.0) 54 (57.5) 1
Less than one year 13 (13.8) 2 (2.1) 9 (9.6) 3.4 (1.4–8.5)
One year or longer 35 (37.2) 28 (29.8) 31 (32.9) 2.2 (1.1–4.8)
NOTE: Data are no. (%) of participants. OR, unadjusted odds ratio comparing cases to the two control groups combined; CI, confidence interval. NA=non applicable
because of matching.
doi:10.1371/journal.pone.0007193.t001
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population), was not associated with increased risk of infection.
This remained true after studying various dental procedures (tooth
extraction, gum treatment, cavity filling and dental anaesthesia)
separately.
Also in univariate analysis, illiteracy and marriage were
associated with HCV transmission (Table 3). None of the
community-acquired exposures showed a significant increase in
HCV risk but all of studied high risk habits were associated with
increases in HCV risk: drinking alcohol (OR=2.6; 95% CI=1.3–
5.3), multiple sexual partners (OR=3.5; 95% CI=1.1–11.6) and
IDU (OR=8.5; 95% CI=2.1–33.8) as well as sniffing drugs
(OR=3.6; 95% CI=1.5–8.4).
Among the factors that could not be evaluated for their
significance due to low exposure prevalence were hospitalization in
intensive care unit, IV catheter, endoscope, laparoscopy, ascites
tapping, biopsy, schlerotherapy for varicose, electromyogram and
blood transfusion.
In multivariate analysis (Table 4), the following risk factors were
independently associated with an increase in HCV risk: therapeu-
tic intravenous injections (OR=5.0; 95% CI=1.2–20.2), medical
stitches (OR=4.2; 95% CI=1.6–11.3), sniffing illicit drugs
(OR=4.4; 95% CI=1.6–12.1) and injection drug use
(OR=7.9; 95% CI=1.4–43.5). Being recently married versus
being single (OR=3.3; 95% CI=1.1–9.9), and being illiterate
(OR=3.9; 95% CI=1.8–8.5) were also associated with HCV
transmission.
Discussion
In this study, three risk factors reflecting direct mechanisms of
HCV transmission have been associated with HCV infection: illicit
drug use, unsafe therapeutic injections and wound stitches. In
addition, illiteracy and recent marriage, indirect mechanisms of
transmission, were also independently associated with HCV
infection. A key strength of this study is the recruitment of
incident cases, allowing detailed assessment of exposures in a well-
defined time period, the one to six months prior to onset of
symptoms. Many published cross-sectional studies have compared
individuals with and without anti-HCV antibodies to identify risk
factors for infection [10,15,16]. These studies, although based on
large numbers, suffered from drawbacks such as approximate
exposure assessment over long periods of time, and the possibility
that exposures followed, rather than antedated, HCV infection.
Case-control studies offer a better design but still information and
selection bias may happen. Regarding information bias, question-
naires in this study were administered at the time patients
presented to the hospital, and prior to knowing whether they had
acute hepatitis C or acute hepatitis A. Therefore, chances that the
Table 3. Community exposures and high risk habits among acute hepatitis C cases and controls sex- and 61 year age-matched,
Greater Cairo, 2002-7.
HCV Cases HAV Controls Family Controls OR
*(95% CI) p-value
Community exposures
c
Shaving at barber
d 54 (81.8) 42 (63.6) 46 (69.7) 2.1 (0.9–4.5) 0.06
Sharing razor blades
d 4 (6.1) 7 (10.6) 11 (16.7) 0.4 (0.2–1.3) 0.14
Manicure 1 (1.1) 3 (3.2) 2 (2.1) 0.4 (0.1–3.4) 0.36
Sharing nail cutter 67 (71.3) 64 (68.1) 78 (82.9) 0.7 (0.4–1.2) 0.20
High risk habits (males)
d
Drinking alcohol 25 (37.9) 15 (22.7) 11 (16.7) 2.6 (1.3–5.3) 0.006
Multiple sexual partners 8 (12.1) 2 (3.0) 5 (7.6) 3.5 (1.1–11.6) 0.004
Illicit drug use: ,0.001
No 33 (50.0) 46 (69.7) 48 (72.7) 1
Sniffing exclusively 19 (28.8) 10 (15.2) 8 (12.1) 3.6 (1.5–8.4)
IDU 9 (13.6) 2 (3.0) 1 (1.5) 8.5 (2.1–33.8)
Missing 5 (7.6) 8 (12.1) 9 (13.7) -
NOTE: Data are no. (%) of participants.
OR
*, unadjusted odds ratio comparing cases to the two control groups combined; CI, confidence interval.
cNeither cases nor controls were circumcised; none had ear piercing, tattoos or acupuncture.
dSince women were not asked, they were excluded from the analysis (N=198; 66 participants per serie).
doi:10.1371/journal.pone.0007193.t003
Table 4. Multivariate analysis showing factors independently
associated with acute hepatitis C, Greater Cairo, 2002-7.
Adjusted OR (95% CI) N=275
e p-value
Intravenous injections 5.0 (1.2–20.2) 0.020
Medical stitches 4.2 (1.6–11.3) 0.004
Illicit drug use:
Never 1
Sniffing 4.4 (1.6–12.1) 0.005
Injection drug use 7.9 (1.4–43.5) 0.018
Marriage duration
Single 1
Less than one year 3.3 (1.1–9.9) 0.029
One year or longer 1.8 (0.8–4.1)
Illiteracy 3.9 (1.8–8.5) 0.001
NOTE: Adjusted OR, odds ratio adjusted by all other covariates; CI, confidence
interval.
e7 participants with missing data: 6 controls with missing information on
intravenous injection and one on duration of marriage.
doi:10.1371/journal.pone.0007193.t004
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these two groups were minimised. Regarding selection bias is
expected to be low since both series of controls were chosen so that
they were ‘‘likely to have consulted at the study hospitals had they
developed the disease of interest’’, and both gave very similar
prevalence estimates for all the exposures under study. Finally, our
strict (61 year) age- and gender matching maximised study power
when it came to control for important potential confounders such
as age and gender.
Acute infection with HCV leads to symptomatic hepatitis only
in ,15% of patients and it is most often diagnosed in the setting of
post-exposure surveillance or seroconversion in high risk individ-
uals (e.g., healthcare professionals or injecting drug users) [17].
One may wonder whether focusing on symptomatic cases might
have biased the study towards the identification of risk factors
more prone to lead to symptomatic forms of infection. However,
we have not found in the literature evidence of factors associated
with symptomatic forms of infection, except for older age [18].
Of interest, partial genotyping information is available for some
patients with acute hepatitis C recruited in the same hospitals: 11
of 12 patients who underwent treatment after 4–6 months of
persistent infection were infected with HCV genotype 4 [19]. And
10 out of 12 of our acute HCV participants involved in a study of
HCV intrafamilial transmission were infected with genotype 4
(Paez Jimenez, personal communication). Others were infected
with genotype 1. These findings are in line with the known
predominance of genotype 4 among HCV-infected Egyptian
subjects [20].
This study supported the important role played by invasive
health care procedures in HCV transmission in this population.
Intravenous injections in the past six months were associated with
a five-fold increase in HCV risk in multivariate analysis.
Conversely, intramuscular injections, although very common
(16.0% of the control population), were not associated with any
increase in HCV risk, suggesting that large hollow-bore needles,
and intravenous placement of needles, are important contributors
to the efficiency of HCV transmission [21]. Similarly, stitches,
which involve repeated percutaneous effractions of the skin with
the same needle, proved to be efficient in transmitting HCV.
Other invasive medical procedures, such as endoscope, laparos-
copy, or blood transfusions, were not associated with increased risk
of HCV transmission, largely as a result of very low numbers of
exposed individuals, limiting the possibility of estimating risks with
sufficient precision. While this does not preclude increased risk of
transmission associated with each procedure, it does suggest that
these procedures contribute little to the HCV spread in this
population, considering the very limited number of exposed
individuals. Of interest, dental care, previously associated with
HCV spread in Southern Italy [22] and although commonly
reported, was not associated with increased risk of HCV
transmission in our study. Neither were community exposures
such as shaving at barbershop, circumcision, ear-piercing,
tattooing, manicure or pedicure previously reported at risk in
other regions [23–25,26].
In high prevalence areas, contaminated medical equipment
seems to be a common HCV thread [4]. Injecting drug use,
leading HCV mode of transmission in low prevalence countries,
has emerged in our study as a HCV risk factor in Greater Cairo.
In wealthy regions [27] but also in Thailand [28], China [29], Iran
[30] or Afghanistan [31], IDUs are suffering an HCV hyper-
endemia with HCV prevalence rates of 48–96%, due to the
collective use of injecting equipment (and drug solution) and the
turnover in injection partners [32] with a higher risk of acquiring
HCV shortly after onset of injection (after 5 years, 50–90% of
users have been exposed to HCV) [33]. In our study, intranasal
drug users were also at increased risk of acquiring HCV. Sniffing
has been previously identified as a HCV risk factor [34,35] and
HCV has been detected in nasal secretions [36,37] but evidence is
not consistent in all studies [38]. This association in our results
could be due to IDUs reporting sniffing instead injecting practices.
In any case, the high proportion of illicit drug use (11% of male
controls, since women were not asked) is most probably a
particularity of urban Egypt compared to rural Egypt. Scale-up
of harm reduction interventions is urgently needed in Greater
Cairo. This will serve not only the control of the HCV epidemic,
but also that of other feared blood-borne agents such as HBV or
the human immunodeficiency virus (HIV).
More puzzling is the association found between marriage and
HCV infection, and particularly recent marriage. Previous studies
in Egypt and elsewhere in the world gave contradictory findings
regarding the risk of HCV transmission between spouses. In rural
areas of Egypt, Magder et al. estimated through mathematical
modelling that 6% of infected individuals acquired infection from
their spouses [39]. On the other hand, cohort studies in Italy and
Turkey found very low rates of intra-spousal transmission of HCV
over several years of follow-up per couple [40,41]. In this study,
the risk of HCV transmission was higher during the first year of
marriage, and decreased afterwards. One way to reconcile the
above-mentioned findings would be to consider that upon first
encounters with an HCV-infected spouse, the most susceptible
individuals would become infected, while others would remain
little susceptible to infection for the rest of their lives. Cohort
studies, which exclude couples with both spouses already infected
at baseline, would only follow less susceptible individuals, hence
documenting very low rates of transmission. Unfortunately, the
study was not able to identify the modes of transmission (e.g.,
sexual, exchange of grooming items) that may have contributed to
inter-spouse transmission, hence limiting the scope of prevention
messages that can be formulated at this stage.
The HCV increased risk related with illiteracy is worth
mentioning. Although previously reported [42–44], one may have
argued that this association was the result of using an improper
control group with hepatitis A patients. Indeed, developing
hepatitis A as an adolescent or young adult, as for controls
recruited in this study, rather than during early childhood, is
associated with higher standards of hygiene, and presumably
higher socio-economical status. Hence, the hepatitis A control
group might have been ‘‘over educated’’ and the acute hepatitis C
group then more likely to belong to lower educational status.
However, comparison with a matched group issued from relatives
of hepatitis C patients also revealed the same difference in
illiteracy, suggesting that low education is genuinely associated
with increased risk of HCV infection. Since the OR associated
with illiteracy was little modified by control for at risk exposures in
multivariate analysis, one may assume that important risk practices
associated with low education were not measured in this study.
Then, illiteracy may reflect an increased vulnerability due to
inadequacy of interpersonal networks providing support
[42,43,45]. In this sense, it speaks for health education campaigns
to be target in priority to the most deprived populations.
To conclude, these findings add to the evidence for the need to
reinforce policies on HCV risk reduction in health care settings
and, for the first time, suggest illicit drug use as an important HCV
risk factor in urban Egypt. Effective HCV prevention program-
ming should focus on availability of supplies, safe equipment and
contaminated waste disposal in addition to adherence to universal
precautions in all health care settings. Campaigns to discourage
people from illicit drug consumption and harm-reduction
HCV Risk Factors in Egypt
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dependence treatment are also necessary. With increasingly
effective anti-HCV therapy, coordinated mass media campaigns
segmented by audience to raise awareness, promote public debate
and reduce stigma towards HCV infected persons should be
considered.
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